Drugs / Autologous regulatory T Cell Product
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02166177 | Jun 2014 → Jan 2018 | liver failure | Guy's and St Thomas' NHS Foundation Trust | Completed | No outcome recorded |
| Phase 1/2 | NCT02129881 | Apr 2014 → Mar 2017 | end stage renal failure | Guy's and St Thomas' NHS Foundation Trust | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous regulatory T cell product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02166177 ↗ |
| Modality | Cell therapy | “regulatory cell therapy” NCT02166177 ↗ |
| Route | Intravenous | “infused intravenously 5 days post renal transplantation” NCT02129881 ↗ |